EVMN · Evommune, Inc.
$11.25
-0.22 (-1.92%)
At close · Jul 28
Market Cap
$405.21M
Shares
36.02M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$13M
+85.7%
FY2025
Net Income
-$68.87M
-3.1%
FY2025
Operating Margin
-623.62%
+376.6pp
FY2025
Diluted EPS
-$11.22
+75.2%
FY2025
Operating Cash Flow
-$76.44M
-31.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 |
|---|---|---|
| $13M | $7M | |
| $74.04M | $64.24M | |
| $20.03M | $12.77M | |
| $600K | $500K | |
| $94.07M | $77.01M | |
| -$81.07M | -$70.01M | |
| -623.62% | -1000.19% | |
| -$80.47M | -$69.51M | |
| $3.32M | $3.24M | |
| $12.2M | $3.21M | |
| -$68.87M | -$68.31M | |
| $0 | $0 | |
| -$68.87M | -$66.81M | |
| -529.77% | -954.4% | |
| USD/shares | -$11.22 | -$45.29 |
| USD/shares | -$11.22 | -$45.29 |
| shares | 6.14M | 1.51M |
| shares | 6.14M | 1.51M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.